A. Leunis

The costs of initial treatment for patients with acute myeloid leukemia in the Netherlands.

M. Jongen‐Lavrencic, P. Huijgens, C. U. Uyl‐de Groot, 2013, Leukemia research.

Mapping QLQ-C30, HAQ, and MSIS-29 on EQ-5D

M. Versteegh, C. U. Uyl‐de Groot, E. Stolk, 2012, Medical decision making : an international journal of the Society for Medical Decision Making.

CNS Central Nervous System CRT Cranial Radiotherapy EORTC European Organisation for Research and Treatment of Cancer EPQ-R Eysenck Personality Questionnaire Revised ESAS Edmonton Symptom Assessment Scale FACIT-fatigue Functional Assessment of Chronic Illness Therapy-Fatigue Fact-an Functional Assess

A. Leunis, S. Horváth, 2013 .

The Development and Validation of a Decision-Analytic Model Representing the Full Disease Course of Acute Myeloid Leukemia

B. Löwenberg, C. U. Uyl‐de Groot, W. Redekop, 2013, PharmacoEconomics.

Impaired health‐related quality of life in acute myeloid leukemia survivors: a single‐center study

B. Löwenberg, C. U. Uyl‐de Groot, W. Redekop, 2014, European journal of haematology.

Mapping QLQ-C 30 , HAQ , and MSIS-29 on EQ-5 D

M. Versteegh, E. Stolk, M. Boggild, 2012 .

Condition-specific preference-based measures: benefit or burden?

M. Versteegh, C. U. Uyl‐de Groot, E. Stolk, 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.